Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)
Makaleler > Tam Makale · 2017
Yazarlar: Hadiye ŞİRİN, Yongjun Wang, Kazuo Minematsu, Ka Sing Lawrence Wong, Pierre Amarenco, Gregory W. Albers, Hans Denison, J. Donald Easton, Scott R. Evans, Peter Held, Jenny Jonasson, Carlos A. Molina, S. Claiborne Johnston
STROKE, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2017, cilt 48, ss 167-177
DOI: 10.1161/strokeaha.116.014891
Özet
Background and Purpose-In the SOCRATES trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes), ticagrelor was not superior to aspirin. Because of differences in patient demographics and stroke disease pattern in Asia, outcomes of ticagrelor versus aspirin were assessed among Asian patients in a prespecified exploratory analysis.